Skip to main content

Table 1 Demographic characteristics of patients

From: Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study

Variable Control Intervention P value
Age (Years) 58.25 ± 13.1 56.93 ± 12.3 0.47
Male/Female 22/16 24/18 0.39
APACHE 22.7 ± 4.26 24.5 ± 5.35 0.57
SOFA 10.7 ± 2.70 12.54 ± 2.65 < 0.001
Pneumonia 0.56
 VAP 12 13
 CAP 10 11
 HAP 18 16
PSI 188.52 ± 52 ± 33.87 194.72 ± 29.83 0.38
CURB-65 3.55 ± 0.71 3.72 ± 0.67 0.26
MV duration (day) 8.92 ± 2.96 4.05 ± 2.29 < 0.001
ICU LOS (day) 14.15 ± 3.12 12.77 ± 3.71 0.07
Vasopressor use (day) 3.39 ± 1,23 2.28 ± 1.24 0.003
Vasopressor dose (microg/min) 8.26 ± 3.58 6.8 ± 3.18 0.14
Need to mechanical ventilationα 9 5 0.24
Mortality 11 6 0.17
Comorbiditiesa AKI 22(55%) 16(40%) P = 0.144
X2 = 6.763
DM 11(27.5%) 25(62.5%)
Cardiovascular 13(32.5%) 18(45%)
Cerebrovascular 8(20%) 11(27.5%)
Malignancy 5(12.5%) 3(7.5%)
  1. APAHE acute physiology and chronic health evaluation SOFA sequential organ failure assessment VAP ventilator associate pneumonia CAP community acquired pneumonia HAP hospital acquired pneumonia PSI pulmonary severity index CURB-65 (confusion, blood urea > 42,8 mg/dl, respiratory rate > 30/min, blood pressure < 90/60 mmHg, age > 65)
  2. aSee chart 1